Streetbeat News

Analyst Ratings

SLGN

Raymond James analyst Matt Roberts has reaffirmed an Outperform rating on Silgan Holdings (NYSE:SLGN) and increased the price target from $49 to $52.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 1:15 pm

AVY

Raymond James analyst Matt Roberts has maintained an Outperform rating on Avery Dennison (NYSE:AVY) and increased the price target from $199 to $225.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 1:13 pm

JLL

Raymond James analyst Patrick O'Shaughnessy has maintained an Outperform rating on Jones Lang LaSalle (JLL) and increased the price target from $173 to $199.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 1:10 pm

CWK

Raymond James analyst Patrick O'Shaughnessy has reaffirmed a Strong Buy rating on Cushman & Wakefield (NYSE:CWK) and increased the price target from $11 to $12.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 1:09 pm

MLM

Martin Marietta Materials (NYSE:MLM) has been the subject of varying opinions from 5 analysts over the past three months, with ratings ranging from bullish to bearish. The average 12-month price target is $558.6, marking a 10.07% increase from the previous target of $507.50. Analysts from firms like Raymond James, Morgan Stanley, Stifel, and Stephens & Co. have raised their price targets, reflecting a positive outlook on the company's performance. Martin Marietta Materials, a major producer of construction aggregates, has shown strong revenue growth and net margin but faces challenges with ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 1:01 pm

ABT

Analysts have recently provided various updates on Abbott Laboratories (NYSE:ABT), with 4 somewhat bullish ratings in the last three months. The average 12-month price target for ABT has risen to $125.00, up from $117.25. Key analysts from firms like Raymond James and Wells Fargo have raised their price targets, reflecting a positive outlook on the company's performance. Despite a negative revenue trend of -2.56% over the last quarter, Abbott's net margin and ROA are strong, and its debt management is sound. The company is a major player in the healthcare sector, with a diverse product portfolio and significant international sales.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 1:00 pm

FWRG

First Watch Restaurant Gr (NASDAQ:FWRG) has received mixed analyst ratings over the past three months, with a recent average 12-month price target of $22.75, up from $21.75. The company has shown strong revenue growth and net margin but lags in ROE and ROA. Analysts from Raymond James and Barclays have raised their price targets, while Stifel has lowered theirs.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 1:00 pm

VMC

Vulcan Materials (NYSE:VMC) has been analyzed by 5 analysts, showing a range of opinions. The average 12-month price target is $237.6, with a high of $279.00 and a low of $208.00, reflecting a slight decrease from the previous average of $240.00. Analyst actions include rating changes and price target adjustments, with some raising and others maintaining or lowering their targets. Vulcan Materials is a major producer of construction aggregates in the U.S. with significant market presence but faces challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 1:00 pm

CBRE

Raymond James analyst Patrick O'Shaughnessy has reaffirmed a Strong Buy rating on CBRE Group (NYSE:CBRE) and increased the price target from $95 to $103.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 1:00 pm

VMC

Raymond James analyst Patrick Tyler Brown has maintained an Outperform rating on Vulcan Materials (NYSE:VMC) and increased the price target from $225 to $240.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 12:57 pm